Cargando…
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101362/ https://www.ncbi.nlm.nih.gov/pubmed/21188408 http://dx.doi.org/10.1007/s00415-010-5876-x |
_version_ | 1782204278244376576 |
---|---|
author | Jesse, Sarah Brettschneider, Johannes Süssmuth, Sigurd D. Landwehrmeyer, Bernhard G. von Arnim, Christine A. F. Ludolph, Albert C. Tumani, Hayrettin Otto, Markus |
author_facet | Jesse, Sarah Brettschneider, Johannes Süssmuth, Sigurd D. Landwehrmeyer, Bernhard G. von Arnim, Christine A. F. Ludolph, Albert C. Tumani, Hayrettin Otto, Markus |
author_sort | Jesse, Sarah |
collection | PubMed |
description | In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine parameters are generally lacking. The objective of the study was to define a normal reference spectrum of routine CSF parameters in neurodegenerative diseases. Routine CSF parameters (white cell count, lactate and albumin concentrations, CSF/serum quotients of albumin (Q (alb)), IgG, IgA, IgM, and oligoclonal IgG bands (OCB)) were retrospectively analyzed in an academic research setting. A total of 765 patients (Alzheimer’s disease (AD), Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), vascular dementia (VD), frontotemporal lobar degeneration (FTLD), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), motor neuron diseases (MND), spinocerebellar ataxia (SCA), Huntington’s disease (HD)) and non-demented control groups including a group of patients with muscular disorders (MD). The main outcome measures included statistical analyses of routine CSF parameters. Mildly elevated Q (alb) were found in a small percentage of nearly all subgroups and in a higher proportion of patients with PSP, MSA, VD, PDD, and MND. With the exception of 1 MND patient, no intrathecal Ig synthesis was observed. Isolated OCBs in CSF were sometimes found in patients with neurodegenerative diseases without elevated cell counts; lactate levels were always normal. A slightly elevated Q (alb) was observed in a subgroup of patients with neurodegenerative diseases and does not exclude the diagnosis. Extensive elevation of routine parameters is not characteristic and should encourage a re-evaluation of the clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-010-5876-x) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-3101362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-31013622011-07-14 Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases Jesse, Sarah Brettschneider, Johannes Süssmuth, Sigurd D. Landwehrmeyer, Bernhard G. von Arnim, Christine A. F. Ludolph, Albert C. Tumani, Hayrettin Otto, Markus J Neurol Original Communication In neurodegenerative diseases, cerebrospinal fluid analysis (CSF) is predominantly performed to exclude inflammatory diseases and to perform a risk assessment in dementive disorders by measurement of tau proteins and amyloid beta peptides. However, large scale data on basic findings of CSF routine parameters are generally lacking. The objective of the study was to define a normal reference spectrum of routine CSF parameters in neurodegenerative diseases. Routine CSF parameters (white cell count, lactate and albumin concentrations, CSF/serum quotients of albumin (Q (alb)), IgG, IgA, IgM, and oligoclonal IgG bands (OCB)) were retrospectively analyzed in an academic research setting. A total of 765 patients (Alzheimer’s disease (AD), Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), vascular dementia (VD), frontotemporal lobar degeneration (FTLD), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), motor neuron diseases (MND), spinocerebellar ataxia (SCA), Huntington’s disease (HD)) and non-demented control groups including a group of patients with muscular disorders (MD). The main outcome measures included statistical analyses of routine CSF parameters. Mildly elevated Q (alb) were found in a small percentage of nearly all subgroups and in a higher proportion of patients with PSP, MSA, VD, PDD, and MND. With the exception of 1 MND patient, no intrathecal Ig synthesis was observed. Isolated OCBs in CSF were sometimes found in patients with neurodegenerative diseases without elevated cell counts; lactate levels were always normal. A slightly elevated Q (alb) was observed in a subgroup of patients with neurodegenerative diseases and does not exclude the diagnosis. Extensive elevation of routine parameters is not characteristic and should encourage a re-evaluation of the clinical diagnosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-010-5876-x) contains supplementary material, which is available to authorized users. Springer-Verlag 2010-12-25 2011 /pmc/articles/PMC3101362/ /pubmed/21188408 http://dx.doi.org/10.1007/s00415-010-5876-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Communication Jesse, Sarah Brettschneider, Johannes Süssmuth, Sigurd D. Landwehrmeyer, Bernhard G. von Arnim, Christine A. F. Ludolph, Albert C. Tumani, Hayrettin Otto, Markus Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title_full | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title_fullStr | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title_full_unstemmed | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title_short | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
title_sort | summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101362/ https://www.ncbi.nlm.nih.gov/pubmed/21188408 http://dx.doi.org/10.1007/s00415-010-5876-x |
work_keys_str_mv | AT jessesarah summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT brettschneiderjohannes summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT sussmuthsigurdd summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT landwehrmeyerbernhardg summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT vonarnimchristineaf summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT ludolphalbertc summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT tumanihayrettin summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases AT ottomarkus summaryofcerebrospinalfluidroutineparametersinneurodegenerativediseases |